- Home
- GAME vs EDSA Comparison
GAME vs EDSA Comparison
Compare GAME & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GAME | EDSA |
|---|---|---|
| Founded | 2011 | 2015 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.4M | 51.5M |
| IPO Year | 2024 | 2018 |
Fundamental Metrics
Financial Performance| Metric | GAME | EDSA |
|---|---|---|
| Price | $2.48 | $2.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $11.33 | ★ $16.33 |
| AVG Volume (30 Days) | 78.3K | ★ 2.9M |
| Earning Date | 11-16-2026 | 12-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.14 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $44,999,302.00 | N/A |
| Revenue This Year | $91.12 | N/A |
| Revenue Next Year | $47.60 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.24 | $0.72 |
| 52 Week High | $3.85 | $20.32 |
Technical Indicators
Market Signals| Indicator | GAME | EDSA |
|---|---|---|
| Relative Strength Index (RSI) | 41.42 | 35.10 |
| Support Level | $0.32 | $0.83 |
| Resistance Level | $2.84 | $4.27 |
| Average True Range (ATR) | 0.19 | 0.34 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 39.71 | 14.90 |
Price Performance
Historical ComparisonAbout GAME GameSquare Holdings Inc.
GameSquare Holdings Inc is a vertically integrated digital media, entertainment, and technology company focused on gaming and youth culture audiences. The company operates through four reportable segments: Owned and Operated IP, Agency, SaaS and managed services, and Yield. It provides services including influencer marketing, esports talent management, creative production, merchandise and consumer products, live streaming analytics, and digital media solutions through its various brands and platforms. It generates the majority of its revenue from the Agency segment.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.